Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
DSMB Has Reviewed Interim Clinical and Safety Data and Recommended that the Study Continue
Want to get your story featured as above? click here!
Want to get your story featured as above? click here!